Toward the Discovery of a Novel Class of YAP-TEAD Interaction Inhibitors by Virtual Screening Approach Targeting YAP-TEAD Protein-Protein Interface

被引:37
|
作者
Gibault, Floriane [1 ]
Coevoet, Mathilde [1 ]
Sturbaut, Manon [1 ]
Farce, Amaury [2 ]
Renault, Nicolas [2 ]
Allemand, Frederic [3 ]
Guichou, Jean-Francois [3 ]
Drucbert, Anne-Sophie [4 ]
Foulon, Catherine [4 ]
Magnez, Romain [1 ]
Thuru, Xavier [1 ]
Corvaisier, Matthieu [1 ]
Huet, Guillemette [1 ]
Chavatte, Philippe [2 ]
Melnyk, Patricia [1 ]
Bailly, Fabrice [1 ]
Cotelle, Philippe [1 ,5 ]
机构
[1] Univ Lille, CHU Lille, INSERM,UMR S 1172, JPArc,Ctr Rech Jean Pierre Aubert Neurosci & Canc, F-59000 Lille, France
[2] Univ Lille, CHU Lille, LIRIC Lille Inflammat Res Int Ctr, INSERM,U995, F-59000 Lille, France
[3] Univ Montpellier, Ctr Biochim Struct, CNRS, INSERM,U1054,UMR5048, 29 Rue Navacelles, F-34090 Montpellier, France
[4] Univ Lille, CHU Lille, Plate Forme Interact Mol, F-59000 Lille, France
[5] ENSCL, F-59000 Lille, France
关键词
protein-protein interaction; YAP-TEAD disruption; molecular docking; binding assays; anticancer; ORGAN SIZE CONTROL; HIPPO PATHWAY; DOWNSTREAM EFFECTORS; CELL-PROLIFERATION; EMERGING ROLES; CANCER; YAP/TAZ; TAZ; COACTIVATORS; COMPLEX;
D O I
10.3390/cancers10050140
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Intrinsically disordered protein YAP (yes-associated protein) interacts with TEADs transcriptional factors family (transcriptional enhancer associated domain) creating three interfaces. Interface 3, between the Omega-loop of YAP and a shallow pocket of TEAD was identified as the most important TEAD zone for YAP-TEAD interaction. Using the first X-ray structure of the hYAP(50-71)-hTEAD1(209-426) complex (PDB 3KYS) published in 2010, a protein-protein interaction inhibitors-enriched library (175,000 chemical compounds) was screened against this hydrophobic pocket of TEAD. Four different chemical families have been identified and evaluated using biophysical techniques (thermal shift assay, microscale thermophoresis) and in cellulo assays (luciferase activity in transfected HEK293 cells, RTqPCR in MDA-MB231 cells). A first promising hit with micromolar inhibition in the luciferase gene reporter assay was discovered. This hit also decreased mRNA levels of TEAD target genes.
引用
收藏
页数:14
相关论文
共 28 条
  • [1] Targeting the YAP-TEAD interaction interface for therapeutic intervention in glioblastoma
    Saunders, Jacquelyn T.
    Holmes, Brent
    Benavides-Serrato, Angelica
    Kumar, Sunil
    Nishimura, Robert N.
    Gera, Joseph
    JOURNAL OF NEURO-ONCOLOGY, 2021, 152 (02) : 217 - 231
  • [2] Optimization of a Class of Dihydrobenzofurane Analogs toward Orally Efficacious YAP-TEAD Protein-Protein Interaction Inhibitors
    Sellner, Holger
    Chapeau, Emilie
    Furet, Pascal
    Voegtle, Markus
    Salem, Bahaa
    Le Douget, Mickael
    Bordas, Vincent
    Groell, Jean-Marc
    Le Goff, Anne-Laure
    Rouzet, Christine
    Wietlisbach, Thomas
    Zimmermann, Thomas
    McKenna, Joseph
    Brocklehurst, Cara E. E.
    Chene, Patrick
    Wartmann, Markus
    Scheufler, Clemens
    Kallen, Joerg
    Williams, Gareth
    Harlfinger, Stephanie
    Traebert, Martin
    Dumotier, Berengere M.
    Schmelzle, Tobias
    Soldermann, Nicolas
    CHEMMEDCHEM, 2023, 18 (11)
  • [3] Fluorescence polarization assay for the identification and evaluation of inhibitors at YAP-TEAD protein-protein interface 3
    Zhou, Wei
    Li, Yiping
    Song, Jinhua
    Li, Chenglong
    ANALYTICAL BIOCHEMISTRY, 2019, 586
  • [4] Hot Spot Analysis of YAP-TEAD Protein-Protein Interaction Using the Fragment Molecular Orbital Method and Its Application for Inhibitor Discovery
    Kim, Jongwan
    Lim, Hocheol
    Moon, Sungho
    Cho, Seon Yeon
    Kim, Minhye
    Park, Jae Hyung
    Park, Hyun Woo
    No, Kyoung Tai
    CANCERS, 2021, 13 (16)
  • [5] Structure-Based Design and Synthesis of Potent Cyclic Peptides Inhibiting the YAP-TEAD Protein-Protein Interaction
    Zhang, Zhisen
    Lin, Zhaohu
    Zhou, Zheng
    Shen, Hong C.
    Yan, S. Frank
    Mayweg, Alexander V.
    Xu, Zhiheng
    Qin, Ning
    Wong, Jason C.
    Zhang, Zhenshan
    Rong, Yiping
    Fry, David C.
    Hu, Taishan
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (09): : 993 - 998
  • [6] Structure-based design of potent linear peptide inhibitors of the YAP-TEAD protein-protein interaction derived from the YAP omega-loop sequence
    Furet, Pascal
    Salem, Bahaa
    Mesrouze, Yannick
    Schmelzle, Tobias
    Lewis, Ian
    Kallen, Joerg
    Chene, Patrick
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (16) : 2316 - 2319
  • [7] Identification of Celastrol as a Novel YAP-TEAD Inhibitor for Cancer Therapy by High Throughput Screening with Ultrasensitive YAP/TAZ-TEAD Biosensors
    Nouri, Kazem
    Azad, Taha
    Ling, Min
    van Rensburg, Helena J. Janse
    Pipchuk, Alexander
    Shen, He
    Hao, Yawei
    Zhang, Jianmin
    Yang, Xiaolong
    CANCERS, 2019, 11 (10)
  • [8] The First Class of Small Molecules Potently Disrupting the YAP-TEAD Interaction by Direct Competition
    Furet, Pascal
    Bordas, Vincent
    Le Douget, Mickael
    Salem, Bahaa
    Mesrouze, Yannick
    Imbach-Weese, Patricia
    Sellner, Holger
    Voegtle, Markus
    Soldermann, Nicolas
    Chapeau, Emilie
    Wartmann, Markus
    Scheufler, Clemens
    Fernandez, Cesar
    Kallen, Joerg
    Guagnano, Vito
    Chene, Patrick
    Schmelzle, Tobias
    CHEMMEDCHEM, 2022, 17 (19)
  • [9] Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides
    Zhou, Zheng
    Hu, Taishan
    Xu, Zhiheng
    Lin, Zhaohu
    Zhang, Zhisen
    Feng, Teng
    Zhu, Liangcheng
    Rong, Yiping
    Shen, Hong
    Luk, John M.
    Zhang, Xiongwen
    Qin, Ning
    FASEB JOURNAL, 2015, 29 (02) : 724 - 732
  • [10] Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking
    Smith, Sarah A.
    Sessions, Richard B.
    Shoemark, Deborah K.
    Williams, Christopher
    Ebrahimighaei, Reza
    McNeill, Madeleine C.
    Crump, Matthew P.
    McKay, Tristan R.
    Harris, Gemma
    Newby, Andrew C.
    Bond, Mark
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (03) : 1291 - 1305